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INTRODUCTION 
Salivary glands are one of the important exocrine glands. They are 
classified according to size as major (eg. Parotid, Submandibular and 
sublingual) and minor (eg. Lip, mounth and throat) glands. Their 
secretion may be serous, mucous or mixed. Saliva secreted from these 
glands keeps the oral mucosa moist and carbohydrate digestion starts in 
the mouth by ptyalin. 
Salivary gland lesions range from inflammation to neoplasm. 
Salivary gland lesions constitute 2.68% of oral mucosal lesions, Sajeevan 
et al (2003). The salivary glands are the site of origin of a wide variety of 
neoplasms. The histopathology of these tumours in said to be the most 
complex and diverse of any organ in the body. Salivary gland neoplasm 
are also relatively uncommon and they constitute about 3% of all head 
and neck neoplasms. About 80% of tumours located in parotid gland, 10-
20% in submandibular gland and several percentage in sublingual and 
minor salivary gland ,Wierzbicka et al( 2010). Benign neoplasm make up 
about 80% of parotid tumours, 50% of submandibular tumours and less 
than 40% of sublingual and Minor salivary gland tumours ,Eisele et al      
(2001). 
 
 
 
 
AIMS AND OBJECTIVES 
The aim of the study is to  
1. Record the incidence of salivary gland lesions reported to 
Tirunelveli Medical College Hospital. 
2. Classify the lesions into inflammatory, neoplastic and others. 
3. Categorise the neoplastic lesions as per the WHO classification. 
4. Compare and analyze our data with similar studies . 
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REVIEW OF LITERATURE 
SALIVARY GLAND LESION 
Salivary gland structure  
There are three major paired salivary glands (parotid, 
submandibular, sublingual) and numerous minor salivary glands 
(submucosa of the upper aerodigestive tract i.e. lips and nasal cavity to 
major bronchi). These exocrine glands secrete components of saliva that 
lubricate the food and breakdown carbohydrates. 
Macroscopic 
Parotid glands composed of a superficial lobe and deeper smaller 
lobe and facial nerve runs between the two lobes. Each gland contains 
about 20 intraglandular lymphnodes. Most salivary gland tumors arise 
from the superficial lobe and present as facial swellings. Tumors that 
occur in the deep lobe often expand through the parapharyngeal space, 
manifesting as pharyngeal swelling, Kaplan M and Johns M (1993). The 
accessory lobe of the parotid gland, situated adjacent to Stenson’s duct 
and separate from the main body of the parotid gland, is found in 21% of 
normal subjects, Frommer J et al (1977). Tumors arising in this lobe often 
present as midcheek masses, Lin D T et al (2004). Parotid secrete serous 
fluid and empty into oral cavity near second maxillary molar via 
Stensen’s duct.  
Submandibular (submaxillary) glands secrete serous and mucous 
fluids and empty at floor of the mouth through Wharton’s duct. 
Sublingual glands secrete serous and mucous fluid, partly empty at floor 
of the mouth through Bartholin’s duct  directly and partly coalesce to 
empty into Wharton’s duct. Both the Bartholin’s duct and Wharton’s duct 
open in the floor of the mouth on either side of the tongue frenulum. 
Minor salivary glands can be found in the lateral margins of the tongue, 
lips, buccal mucosa, palate, and glossopharyngeal area. Among them, the 
palate is the site of predilection for salivary gland neoplasms. The minor 
glands are seromucinous or predominantly mucous, depending on 
location. 
Microscopic 
Major glands are enclosed by connective tissue capsule and divided  
into lobules composed of ducts and acini. Minor salivary glands are not 
capsulated. Preservation of the lobular architecture is an important feature 
favoring a diagnosis of a non-neoplastic process over a tumor.  The entire 
glandular structure is a two-tiered organization which comprises luminal 
(acinar and ductal cells) and abluminal (myoepithelial and basal cells). 
The acini are lined by epithelial cells surrounded by myoepihelial cells 
which lie between acinar cell and basement membrane. The striated ducts 
and the downstream conducting units are lined by simple or 
pseudostratified columnar epithelium which gradually transforms into 
stratified squamous epithelium in the salivary duct, as they reach the oral 
epithelium and they are supported by basal cells.  
The acinar portion of all Salivary glands are composed of either 
serous or mucinous cells.  Serous cells are pyramidal in shape contain 
periodic acid schiff (PAS) positive and mucicarmine negative granules 
within their cytoplasm and large basel nucleus. Mucous cells are rounder 
cuboidal to columnar with small basally oriented nuclei and finely 
vacuolated cytoplasm containing sialomucins. They are PAS-positive and 
mucicarmine positive. The luminal cells of the intercalated ducts are 
cuboidal, with eosinophilic to amphophilic cytoplasm  and centrally 
located nuclei. The striated ducts are lined by columnar cells with 
granular cytoplasm which are mitochondria rich and subnuclear vertical 
striations due to the prominent basal folds in the plasma membrane. The 
luminal cells are readily highlighted by immunostaining for cytokeratin, 
carcinoembryonic antigen (CEA), and epithelial membrane antigien 
(EMA). 
Myoepithelial cells are physiologically and functionally modified 
epithelial cells situated between the luminal cells and the basement 
membrane. They are stellate-shaped with cytoplasmic processes 
embracing the acini or spindle-shaped surrounding the intercalated ducts. 
They possess a dual epithelial and smooth muscle phenotype 
characterized ultrastructurally by the presence of desmosomes, 
intermediate filaments, pinocytotic vesicles, and myofilaments, Dardick I 
(1996).  They may also exert an anti-invasive effect in neoplasms by 
promoting epithelial differentiation, secreting proteinase inhibitors, and 
suppressing angiogenesis, Savera A T and Zarbo R J (2004). 
The abluminal cells in the striated ducts, excretory ducts, and 
salivary ducts are basal cells, which differ ultrastructurally from 
myoepithelial cells in the absence of myofilaments. They play an 
important role in the processes of regeneration and metaplastic changes, 
Ihrler S et al (2002). Oncocytic cells, seen after 50 years of age replaces 
the normal cells of ductoacinar units. Oncocytic metaplasia has been 
implicated in the development of oncocytic hyperplasia, nodular 
oncocytosis, and even oncocytoma, Krech R et al (1981). 
Epidemiology 
The distribution of salivary gland lesions were recorded almost all 
parts of the world. But the incidence level varies for different parts of the 
world. The different level of salivary gland lesions occured were 2.68% 
of oral lesions in northern Tamilnadu, Sajeevan et al (2003), 141 per 8 
years in Malaysia, Jayaram  and Dashini (2011), 185 per 3 years in West 
Bengal, Bandyopadhyay et al (2005), 3.5% of head and neck tumour over 
21 years in Nigeria,  Kolude et al (2001), 1.9% of total cases over 41 
years in Thailand, Dhanuthai et al (2009), 0.15% of total cases over 20 
years in Portuguese, Lima et al (2005). 
Sialadenitis 
Inflammation of the salivary gland is called sialadenitis. It may be 
due to the following reasons.  
• Mechanical – obstruction 
• Physical   - Radiation, Seifert G et al (1986) 
• Infections :   
¾ Bacterial (staphylococcus aureus, streptococci – acute  
suppurative sialadenitis). Clinical signs include tender, 
diffuse or  localized swelling that may fluctuate, later 
fistula draining purulent material may form (Seifert G et al., 
1986).  Microscopically edema, hyperemia and acute 
inflammation  and periductal or intraductal accumulation of 
neutrophils and destruction of ductal epithelium.  Acini lost and  
paranchymal  microabscesses form. 
¾ Viral - Paramyxo in mumps, Coxsackie, EpsteinBarr, Influenza 
A  (Seifert G et al.,1986). Mumps clinically swollen and 
painful. Microscopically dense interstitial lymphoplasmocytic 
infiltrate,   acinar cell vacuolization and ductal dilatation, Seifert 
G et al (1986); Hanson D et al (1971). 
• Autoimmune - Sjogren syndrome, Rheumatoid arthritis, 
Hyper gammaglobulinemia. Early stage there is 
lymphoplasmocytic septal inflammatory infiltrate. Sever stage 
extensive lymphoid infiltrate with germinal centers, acini  atrophic, 
interstitial fibrosis. In late stages acini are absent and ducts with 
intraepithelial lymphocytes, Bloch KS et al (1965). 
 
Chronic sialadenitis 
The causes for chronic sialadenitis are Sialolithiasis, Autoimmune, 
Radiation therapy and duct strictures. Grossly there is hard, fibrotic 
gland. Microscopically in early stage dilated ducts filled with secretions 
& lymphoplasmacytic infiltrate. Later stage fibrosis around duct & 
lobulation of gland with acinar atrophy. Differential diagnosis include 
lymphoepithelial lesion or Warthin’s tumor in which epithelial 
component present in both condition. Treatment is surgical removal. 
Sialolithiasis 
Various calcified masses that form in the ducts of salivary glands. 
They form from the calcification of an intraluminal organic nidus such as 
a dried secretion, bacterial colonies or cellular debris. Their exact cause is 
not known, but inflammation of the salivary duct and the viscosity and 
stasis of saliva have been suggested as predisposing factors, Koudelka 
BM (1991); Shafer WG et al (1983).  The stones are predominantly 
composed of calcium phosphate in the form of hydroxyapatite, Anneroth 
G et al (1975). 
Clinical signs include distention of the duct, swelling and pain. 
Grossly there is round or oval stone with  smooth or rough surface, colour 
varying from white to yellow. Microscopically duct epithelium is  
compressed and may show squamous, oncocytic or mucous cell 
metaplasia. Recurrent infection and retention of secretions lead to 
parenchymal atrophy and scarring of the gland. Diagnosis can be made by 
radiological imaging studies and the treatment is removal of the stone and 
affected portion of the gland. 
Mucoceles 
Pooling of mucin in a cystic cavity is called mucocele.  The two 
types of mucoceles are retention type in which mucin in dilated duct and 
extravasation type where mucin accumulates in soft tissue. Common sites 
affected are lower lip, tongue, floor of the mouth (ranula) and buccal 
mucosa and incidence is more in the third decade of life. 
Grossly cystic cavity in the connective tissue filled with glistening 
fluid. Microscopically cyst wall may or may not contain epithelial lining. 
The retention type has lining and no surrounding inflammation. In 
extravasation type there is mucin with surrounding inflammatory cells 
and no lining seen, there will be foamy histiocytes. Treatment  for 
mucocele is surgical excision. 
Benign lymphoepithelial cysts 
Benign lymphoepithelial cysts are unifocal lesions and seen in fifth 
and sixth decades of life.  These cysts are unilateral and always occur in 
parotid gland, sometimes oral cavity is affected. Grossly well 
circumscribed unilobular cysts with serous to mucoid to caseous and 
keratinous debris may present. 
Microscopically cyst is seen lined by benign mature squamous 
epithelium without papillary projections, rarely cuboidal or columnar 
with goblet cells. Below the epithelium, the cyst wall has dense lymphoid 
tissue with germinal centers. The treatment for benign lymphoepithelial 
cyst is excision of the cysts. 
NEOPLASMS 
The worldwide annual incidence of salivary gland tumors ranges 
from 0.4 to 13.5 cases per 100 000 people, Auclair P L et al (1991). In 
general, salivary gland tumors are most common in older adults and 
females are more commonly affected than males, except for Warthin 
tumor and high-grade carcinomas. Epithelial tumors constitute 80-90% of 
all salivary gland tumors, with the majority being benign (75%), and 
pleomorphic adenoma is the commonest (about 65% of all tumors). The 
parotid gland is the commonest site for occurrence of salivary gland 
tumors. 
Primary carcinomas of the salivary glands are uncommon, 
accounting for fewer than 0.3% of all cancers. The sites of occurrence 
with respect to the number of cases in descending order are: parotid 
gland, submandibular gland, palate, cheek, and tongue. However, tumors 
have the highest chance of being malignant if they arise from the 
retromolar area (89.7%), floor of mouth (88.2%), tongue (85.7%), and 
sublingual gland (70.2%), Ellis G L et al (1991), while only 
approximately 20% of all parotid tumors are malignant. Among the 
salivary gland carcinomas, the commonest histologic types in descending 
order are: mucoepidermoid carcinoma, adenoid cystic carcinoma, adeno-
carcinoma not otherwise specified (NOS) and acinic cell carcinoma, with 
polymorphous low-grade adenocarcinoma (PLGA) replacing 
adenocarcinoma NOS in the minor salivary glands, Kokemueller H et al 
(2004); Wahlberg P et al (2002).  
Facial nerve paralysis is a more consistent sign of malignancy,  
more often seen in high-grade tumors such as squamous cell carcinoma 
and undifferentiated carcinoma, although it can also rarely occur in 
Warthin tumor and Pleomorphic adenoma, Seifert G et al (1986). In 
patients under the age of 18, half of the epithelial tumors are malignant, 
with low-grade mucoepidermoid carcinoma being the commonest,  
Seifert G et al (1986); Da Cruz Perez   D E et al (2004).  
Some salivary gland carcinoma are biologically low-grade          
(eg. acinic cell carcinoma, PLGA, basal cell adenocarcinoma, epithelial-
myoepithelial carcinoma, clear cell carcinoma, cystadenocarcinoma) and  
some are biologically high-grade (eg. salivary duct carcinoma, most cases 
of carcinoma, ex pleomorphic adenoma, undifferentiated carcinoma, 
oncocytic carcinoma) 
Rare salivary gland tumors show hybrid features. Hybrid tumor 
refers to a tumor that is composed of two or more histologically distinct 
components at a single site, Seifert G et at (1996). The most common 
components of hybrid carcinomas are salivary duct carcinoma, epithelial-
myoepithelial carcinoma, and adenoid cystic carcinoma, Seifert G et at 
(1996); Ruiz-Godoy L M et al (2003). Others include mucoepidermoid 
carcinoma, acinic cell carcinoma, squamous cell carcinoma, basal cell 
adenocarcinoma, and PLGA, Seifert G and Donath K(1996); Zardawi I M 
et al (2000). Treatment is probably best based on the histologic 
component with higher-grade malignancy, Ruiz-Godoy L M et al (2003). 
The tumours are classified based on differentiation of components 
of salivary gland (aciner cell, myoepithelial cell or ductal cell) as follows 
WHO Histological Classification of Tumors of the Salivary 
Glands, Eveson et al (2005) 
Malignant epithelial tumors 
Acinic cell carcinoma 
Mucoepidermoid carcinoma 
Adenoid cystic carcinoma 
Polymorphous low-grade 
adenocarcinoma 
Epithelial-myoepithelial 
carcinoma 
Clear cell carcinoma, not 
otherwise specified 
Basal cell adenocarcinoma 
Sebaceous carcinoma 
Sebaceous 
lymphadenocarcinoma 
Cystadenocarcinoma 
Low-grade cribriform 
cystadenocarcinoma 
Mucinous adenocarcinoma 
Oncocytic carcinoma 
Salivary duct carcinoma 
Adenocarcinoma, not otherwise         
specified 
Myoepithelial carcinoma 
Carcinoma ex pleomorphic 
adenoma 
Carcinosarcoma 
Metastasizing pleomorphic 
adenoma 
Squamous cell carcinoma 
Small cell carcinoma 
Large cell carcinoma 
Lymphoepithelial carcinoma 
Sialoblastoma 
Benign epithelial tumors 
Pleomorphic adenoma  
Myoepithelioma  
Basal cell adenoma  
Warthin's tumor  
Oncocytoma  
Canalicular adenoma  
Sebaceous adenoma  
Lymphadenoma  
Sebaceous  
Non-sebaceous  
Ductal papillomas 
Inverted ductal papilloma  
Intraductal papilloma  
Sialadenoma papilliferum  
Cystadenoma 
Soft tissue tumors 
Hemangioma 
Hematolymphoid tumors
Hodgkin's lymphoma 
Diffuse large B-cell 
lymphoma 
Extranodal marginal zone 
B-cell lymphoma 
Secondary tumors  
 
  
According to the incidence, most common salivary gland tumours are  
Histologic Classification and Incidence of Benign and 
Malignant Tumors of the Salivary Glands, Ellis et al (1996). 
Benign Malignant 
Pleomorphic adenoma (50%) 
(mixed tumor) 
Warthin tumor (5% to 10%) 
Oncocytoma (1%) 
Other adenomas (5% to 
10%)  
        Basal cell adenoma  
        Canalicular adenoma 
Ductal Papillomas 
Mucoepidermoid carcinoma 
(15%) 
 
Adenocarcinoma (NOS) 
(10%) 
Acinic cell carcinoma (5%) 
Adenoid cystic carcinoma 
(5%) 
Malignant mixed tumor (3% 
to 5%) 
Squamous cell carcinoma 
(1%) 
Other carcinomas (2%) 
 
Benign neoplasms 
Pleomorphic adenoma 
Pleomorphic adenoma is the most common salivary gland tumour. 
The glands mostly affected are parotid gland, hard palate and  
submandibular gland. Pleomorphic adenoma occurs more frequently in 
women then men, and is most prevalent from the fourth to sixth decades, 
with a mean age of 45 years. It usually presents as a slow growing and 
painless swelling. When it occurs in the minor glands, ulceration of the 
overlying mucosa or apparent fixation to surrounding tissue can be seen 
rarely. Pleomorphic adenoma can occur in various mucosal sites such as 
nasal cavity, bronchus, skin (also known as Chondroid Syringoma of 
breast, and soft tissues, Badia L et al (1996); Croitoru C M et al (1999). 
Pleomorphic adenoma is a benign neoplasm consisting of cells 
with epithelial (luminal) and myoepithelial (abluminal) differentiation, 
accompanied by variable amounts of characteristic stroma. The diverse 
morphology results from amalgamation of cellular and stromal 
components. The coexistence of apparently epithelial and mesenchymal 
elements gives rise to the synonym “mixed tumor”. Pleomorphic 
adenoma is now widely accepted as a pure epithelial tumor with 
divergent differentiation instead of collision of epithelial and 
mesenchymal tumors. The monoclonal origin of both epithelial and 
mesenchymal elements has also been supported by molecular analysis, 
Noguchi S et al (1996).  
Grossly the size ranges from a few millimeters to several 
centimeters. The tumore is typically thinly encapsulated and solitary. 
Intraoral examples, especially those arising from the palate, may lack a 
well-defined capsule. The cut surface may be rubbery, fleshy, mucoid, or 
glistening, depending on the amount of stroma in the tumor. In areas 
where the capsule is deficient tumor buds may lie in direct contact with 
the adjacent salivary tissue, Lam K H et at (1990).  
Microscopically there is mixture of epithelial and mesenchymal 
elements. Epithelial elements contain ductual structure with myoepithelial 
layer and myoepithelial cells contain spindle, clear, plasmacytoid or 
basaloid elements.  In myxoid type  there is >80% mesenchymal tissue, 
cellular type contain > 80% epithelial tissue and mixed or classic type 
contain equal mixture of these tissues. Histologic appearance consists of 
tubular structures enveloped by myoepithelial mantles submerging in  a 
chondromyxoid stroma. The interface between the tumor islands and the 
stroma is usually poorly demarcated. The myoepithelial mantle radiates 
centrifugally, forming sheets, clusters, lattices, and isolated cells, where 
they appear to “melt” into the sea of stroma which they produce.  
The luminal cell component takes the form of anastomosing 
tubules, cysts, ribbons, and solid sheets. The cells may be columnar, 
cuboidal or flat. The duct lumen may be empty or contain eosinophilic 
colloid like material, which is PAS-positive diastase-resistant and 
variably mucicarmine-positive. Rarely, metaplastic change to squamous, 
sebaceous, oncocytic or clear cells can occur. Myoepithelial or modified 
myoepithelial cells appear as cuboidal, spindle, stellate, plasmacytoid 
hyaline, nondescript epithelioid, and hydropic clear cells. The spindle or 
cuboidal cells surround the ducts in a single layer, thick mantle, or 
radiating corona. They can form nondescript sheets, trabeculae, and even 
cribriform structures. 
Plasmacytoid hyaline cells represent the most distinctive form of 
modified myoepithelial cells, they are oval-shaped with homogeneous 
eosinophilic hyaline cytoplasm. The nucleus is round and eccentrically 
located, with a tendency for peripheral margination of the dense 
chromatin. Stellate or spindle myoepithelial cells occur singly, or form 
anastomosing strands, suspended in an abundant myxoid matrix. 
Uncommonly, myoepithelial cells may merge into squamous nests or 
cystic squamous lined structures filled with keratin, suggesting an ability 
to differentiate towards the squamous lineage. Rarely, skeletal muscle  
differentiation and scattered melanocytes can occur, the latter also 
imparting a pigmented macroscopic appearance to the tumour, Lam P W 
et al (1997); Takeda Y et al (2004). 
The main application of immunohistochemistry is to demonstrate 
the coexistence of glandular and myoepithelial components when the 
diagnosis is uncertain. The glandular component, which may be 
inconspicuous, can be highlighted by EMA, CEA, or c-kit. Currently the 
most reliable markers for the neoplasitc myoepithelial component are p63 
and calponin, Bilal H et al (2003). 
Pleomorphic adenoma shoule be differentiated from Monomorphic 
adenoma, Adenoid cystic carcinoma, PLGA, Epithelial-myoepithelial 
carcinoma, Mucoepiedermoid carcinoma. The treatment of choice is 
complete surgical excision (with rim of uninvolved tissue).  The 
recurrence rates at 5 and 10 years following complete excision are 3.4% 
and 6.3% respectively, Hickman R E et al (1984). Enucleation alone, 
rupture or spillage of tumor during removal, presence of protuberances 
beyond the main tumor, abundance of chondromyxoid stroma, and young 
age are associated with a higher recurrence rate, Laskawi R et al (1998); 
McGregor A D et al (1988). 
Warthin’s tumor (papillary cystadenoma lymphomatosum) 
It is a second most common salivary tumour, Eneroth (1971); Spiro 
R H (1986) and occur only in parotid gland. Most common bilateral or 
multifocal tumor of sixth  or seventh decade and associated with smoking 
and definite male predominance. But now, change is seen probably due to 
a decline in the smoking habit, an established risk factor for this tumor, in 
men, and a reverse trend in women, Yoo G H et al (1994). Studies 
conducted among atomic-bomb survivors suggest that radiation may also 
be implicated in the tumorogenesis, Saku T et al (1997). 
Sudden painful increase in size associated with acute pain (known 
as papillary cystadenoma lymphomatosum syndrome) has been 
postulated to be caused by leakage of fluid into the surrounding tissues 
and retrograde infection from the oral cavity via the Stensen’s duct. 
Rarely, facial nerve palsy may be seen in tumors complicated by 
inflammation and fibrosis, which may be mistaken clinically or 
intraoperatively for carcinoma. Warthin tumor is multicentric in 12-20% 
of patients (either synchronous or metachronous), and bilateral in 5-14%, 
Maiorano E et al (2002). In addition, serial sectioning may reveal 
additional subclinical lesions in 50% of cases. This tumor is sometimes 
seen in association with other benign  salivary gland tumors, especially 
pleomorphic adenoma, Shikhani L T et al (1993).  Grossly  soft, brown or 
yellow mass composed of cyst and the cyst with viscous brown fluid. 
Microscopically cystic and/ or papillary epithelium consists of two layers 
a luminal layer of oncocytic columnar cells supported by a discontinuous 
layer of oncocytic basal cells. The nuclei of the luminal cells appear 
uniform and display palisading towards the free surface. Their brightly 
eosinophilic granular cytoplasm is due to accumulation of mitochondria, 
Shintaku M et al (1997). The basal cells possess round to oval nuclei and 
small but conspicuous nucleoli. The lumens of the cysts contain thick 
proteinaceous secretions, cellular debris, cholesterol crystals, and 
sometimes laminated bodies that resemble corpora amylacea, David R et 
al (1978). Epithelium overlies dense, polyclonal lymphoid component 
forms germinal centers. A distinct layer of basement membrane separates 
the cyst lining from the lymphoid stroma, which consists of small 
lymphocytes and some plasma cells, histiocytes, and mast cells, and may 
show giant cell formation, fibrosis or squamous metaplasia from 
trauma/cyst rupture or after fine needle aspiration. 
Differential diagnosis, typical Warthin tumour has a highly 
distinctive morphology and poses no problem in diagnosis. It differs from 
oncocytoma in the presence of a prominent lymphoid component, 
papillae, and glands rather than trabeculae and packets, and conspicuous 
basal cells (which are inconspicuous in the latter tumor). The squamous 
metaplastic Warthin tumor, particularly if infarcted, can be mistaken for 
squamous or mucoepidermoid carcinoma. Squamous metaplasia of 
Warthin tumor usually lacks keratinization, which is seen in most 
squamous cell carcinomas. In contrast to low-grade mucoepidermoid 
carcinoma, there is no definite infiltrative growth and the tumor cells 
appear more frankly squamous. 
The treament is surgical excision. Superficial parotidectomy or 
enucleation of tumor is curative. The rare recurrences (<20%) are 
believed to represent either a second primary or an expression of 
multifocal tumour, Ebbs S et al (1986). In old patients or those with poor 
surgical risk, observation without surgery may be an option. 
Basal cell adenoma 
It is composed of basaloid cells sharply delineated from the stroma 
by basement membrane-like material. It usually exhibits a monotonous 
solid, trabecular, tubular, or membranous growth pattern. It occur in 
adults and 75% in parotid gland.  Clinically, it is asymptomatic and a 
slow growing mass. 
Grossly it presents as solid, well circumscribed and pink to brown 
cystic tumour. Microscopically the edge of the tumour  contain small cell 
with little cytoplasm, show peripheral palisading and  give basaloid 
appearance. The center of the tumour presents polygonal basaloid cells 
with slightly more cytoplasm and round to oval nucleus and more open 
chromatin.Trabecular of membranous pattern have jig-saw puzzle 
appearance with rounded nests of tumor shaped like puzzle pieces. 
Membranous pattern additionally show hyalinized eosinophilic linear or 
modular basement membrane like material around the nests. 
Basal cell adenoma is immunopositive for pan –cytokeratin, S -
100, smooth muscle actin, muscle – specific actin, Bilala H et al (2003); 
Edwards P C et al (2004); Weber A et al (2002).  
          Basal cell adenoma should be differentiated from Basal cell 
adenocarcinoma and Adenoid cystic carcinoma. These two tumours 
contain infiltrative growth and/or perineural invasion. Simple surgical 
excision is the treatment of choice. Recurrence is rare except for the 
membranous type, which is associated with a recurrence rate of 25% 
because of its multifocal nature. Basal cell adenoma may rarely undergo 
malignant transformation (carcinoma ex monomorphic adenoma 4% )to 
basal cell adenocarcinoma, adenoid cystic carcinoma, salivary duct 
carcinoma, or adenocarcinoma NOS, Nagao T et al (1997) . 
Canalicular adenoma 
 Canalicular adenoma arise from excretory ducts and second most 
common salivary gland lesion of upper lip and always arise from minor 
salivary gland and multifocal in nature. Women and African Americans 
are most affected and peak incidence is in seventh  decade of life. It is 
asymptomatic, fluctuate or firm and presents as submucosal nodule 
growing slowly usually 1 to 2 cm. 
Canalicular adenoma occurs most commonly in the elderly, with a 
mean age of 65 years and mild female predilection, Ellis G L et al (1996). 
It is primarily an oral lesion. The upper lip is the site of predilection, 
which accounts for 74% of the cases, followed by the buccal mucosa 
(12%), palate, and rarely, major salivary glands. The patients present with 
a non-ulcerated, painless mass that grows slowly. Infrequently, multifocal 
nodules, ulceration, necrosis, and bone destruction may be seen. Grossly 
the tumour is not encapsulated but well circumscribed, Rousseau A et al 
(1998) and have tan to pink cystic or solid cut surface. 
 Microscopically long strands or tubules of columnar epithelial cells 
with loose, collagenous stroma and two rows of columnar cells situated 
opposite to each other. Strands take beaded appearance with tubules 
coming together and then separating. Tubule epithelial cells have 
eosinophilic cytoplasm and range from cuboidal to basaloid. The stroma 
is characteristically edematous with many capillaries and sinusoids; it can 
be so loose that tumor strands may appear to be “floating in the air”, Ellis 
G L et al (1996). Diagnosis the tumor cells are positive for cytokeratin, 
vimentin, S-100 protein, and, infrequently to EMA, Zarbo R J et al 
(2000). Treament  is simple local excision. 
Myoepitheliomas 
 Myoepithelioma is a benign tumor composed exclusively, or 
almost exclusively, of neoplastic cells exhibiting myoepithelial 
differentiation. While some investigators require total absence of ductal 
component for this designation, Ellis G L et al (1996) most accept the 
presence of a minor epithelial component (e.g. less than 5-10%), Dardick 
I, (1995). 
 Pleomorphic adenoma, basal cell adenoma, and myo-epithelioma 
can be envisaged to lie on a continuum: myoepithelioma may represent 
an extreme form of basal cell adenoma without a ductal component, 
whereas basal cell adenoma is “pleomorphic adenoma lies in the middle 
of this continuum, Simpson R H et al (1995). 
 Myoepithelioma most frequently affects the parotid gland and 
palate. Less commonly, it can occur in the skin, breast, or soft tissue, 
Hornick J L et al (2003).  Clinically, it presents as a painless mass. The 
peak age is from the third to fifth decade with no sex predilection, Ellis G 
L et al (1996); Simpson R H et al (1995). Grossly it is a well 
circumscribed and encapsulated tumour with tan or white cut surface. 
 Histologically sheets and cords of tumour cell of 4 types are 
present.Spindle cell are interlacing with fascicular growth pattern 
hyaline.Plasmacytoid cells are loosely cohesive myoepithelial cells with      
eosinophilic cytoplasm and eccentric round nuclei.  Clear cell are small 
tubules lined by single layer of cuboidal cell  surrounded by one or more 
layers of clear cells. First two cell types being most common. Either a 
single cell type predominates in a tumor, or there can be a mixture of cell 
types. Myoepitheliomas of the minor glands tend to be composed of 
plasmacytoid cells, and those of the parotid are more often composed of 
spindle or epithelioid cells. The stroma is usually scanty,but variable 
amounts of myxoid or hyaline stroma can be present. Collagenous 
crystalloids in the form of radially arranged and intercellular hyaline 
materials are variably present, Simpson R H et al (1995). All have 
collegenous or myxoid stroma. 
       Myoepitheliomas should be differentiated from Pleomorphic 
adenorma or Basal cell adenoma, Myoepithelial carcinoma and various 
mesenchymal lesions. Myoepithelioma is positive for S-100 and 
Cytokeratin, Simpson RH et al (1995) and  variably reactive for smooth 
muscle actin and Glial fibrillary acid protein (GFAP). The prognosis is 
excellent and recurrence is not expected after complete excision and the 
treatment is simple excision 
Oncocytoma 
 It is a rare tumour and constitute 2.3% of benign salivary tumors 
and occur after sixth decade. Site of occurrence is major on parotid, few 
on submandibular and minor (palate, buccal mucosa) glands. It is a slow 
growing nontender mass and firm, may be multilobulated, mobile on 
examination. Oncocytoma most commonly occurs in the parotid gland of 
older adults without gender predilection, Ellis G L et al (1996); 
Brandwein M S et al (1991), but the submandibular gland can also be 
affected. Radiation exposure to the head and neck region has been 
implicated in the pathogenesis in about 20% of cases; this risk factor is 
also associated with presentation 20 year younger than those without a 
history of irradiation. 
Oncocytoma is a discrete, encapsulated tumor consisting 
exclusively of oncocytes and lacking features of other defined tumor 
types, Thompson LD et al (1996). Oncocytoma, when accompanied by 
lymphoid stroma, can be indistinguishable from a Warthin tumor. 
Alternatively, it has been argued that oncocytoma may represent Warthin 
tumor that lacks lymphoid stroma. Oncocytosis is a diffuse oncocytic 
metaplastic process in the salivary gland, often associated with atrophy of 
the surrounding parenchyma, Palmer T J et al (1990).  
The lobular architecture is, however, preserved. Nodular oncocytic 
hyperplasias consist of multiple nodular proliferations of closely packed 
oncocytes. The nodules are less circumscribed and organized than those 
of oncocytoma and a fibrous capsule is lacking, Palmer T J et al (1990); 
Hartwich RW et al (1990). 
Grossly it is homogenous with smooth surface divided into lobules 
by fibrous tissue. Microscopically sheets, nests or cords of uniform 
oncocytic  cells are large with distinct borders filled with an acidophilic 
granular cytoplasm and the granularity due to mitochondria (60%). 
Which can be highlighted by phosphotungstic acid hematoxylin stain or 
immunostaining with antimitochondrial antibody, Shintaku M et al 
(1997). 
Diagnosis can be done by Phosphotungstic acid hematoxylin, 
Bensleys aniline acid fuchsin and Luxol- fast-blue reaction. Typical 
oncocytoma is not difficult to diagnose, but salivary gland tumors with 
prominent oncocytic change, most notably Warthin tumor, pleomorphic 
adenoma, basal cell adenoma, and the oncocytic variant of 
mucoepidermoid carcinoma are pose challenge to diagnose. Nuclei of 
acinic cell carcinomas are peripherally located, in contrast to the central 
round nuclei in oncocytoma, Brandwein M S et al (1991). Prognosis is 
excellent. Surgical excision is the treatment of choice and recurrence is 
uncommon (0-10%), Brandwein M S et al (1991).  
MALIGNANT  
Mucoepidermoid carcinoma 
Mucoepidermoid carcinoma is a most common malignant tumor in 
adult  and childhood, Ellis GL et al (1996) and composed of mucous, 
intermediate, epidermoid (or squamoid) cells. The  tumor typically 
presents as a slow-growing painless mass. About one-third of patients 
experience tenderness, pain, drainage from the ipsilateral ear, dysphagia, 
and trismus. Facial paralysis is uncommon, except in high-grade tumors, 
Seifert G et al (1986 ). Age of presentation spans from the first to the 
ninth decades, peaking in the fourth decade. There is a slight female 
predilection. The parotid gland (45%) and palate (21%) are the 
commonest sites of occurrence, Ellis G L  et al (1996). 
It is the principal histologic type of radiation-related salivary gland 
carcinoma in survivors of the atomic bombings of Hiroshima and 
Nagaski, Saku T et al (1997). This tumor also occurs with increased 
frequency among children who received high-dose and low-dose 
radiotherapy for leukemia and tinea capitis respectiviely, Modan B et al 
(1998).Mucoepidermoid carcinoma has been described in the nasal 
cavity, paranasal sinuses, nasopharynx, breast, bronchus, thymus, and 
skin, Nonaka D et al (2004); Shhilo K et al (2005); Riedlinger W F et al 
(2005). Typically presents as asymptomatic radiolucent lesion. It usually 
shows low-grade malignant behavior and histology. 
Grossly have solid and cystic components and cyst with mucinous 
material. Microscopically, three cell types are seen as sheets, nests, duct 
like structures or cysts. Intermediate cells predominate and range from 
small basal cells with minimal basophilic cytoplasm to large oval cells 
with pale eosinophilic cytoplasm. Mucin producing cells (Mucocytes) 
occur singly or as clusters and have pale, foamy cytoplasm, distinct cell 
membrane and eccentric small nuclei, frequently line cystic spaces and 
are positive with mucicarmine or PAS stains. Epidermoid or squamoid 
cells have abundant eosinophilic cytoplasm and  vesicular nuclei with 
open chromatin, not truly squamous they lack intercellular bridges, rarely 
true keratinization. 
The stroma is characteristically sclerotic and abundant, with 
chronic inflammatory cell infiltration and occasional extravasated mucin 
pools. Rarely, there can be a dense lymphoplasmacytic infiltrate admixed 
with tumor islands, scattered multinucleated giant cells in the stroma, or 
melanin pigmentation, Auclair P L (1994); Donath K et al (1997). 
Population of clear cells scattered throughout the tumor, having high 
glycogen content, can be demonstrated by PAS staining.  
Low grade Mucoepidermoid carcinoma have cystic, abundant well 
differentiated mucous cells. High grade with solid and predominant 
squamous and intermediate cells. Immunohistochemically positive for 
cytokeratin. There can be variable staining for EMA, CEA, and S-100. 
p63 immunoreactivity can be demonstrated in the intermediate, squamous 
and clear cells, Bilal H et al (2003). Mucoepidermoid carcinoma often 
expresses CK7, Nikitakis N G et al (2004). It can be differentiated from 
Necrotizing sialometaplasia by presence of normal lobules of minor 
salivary gland, necrosis, dense inflammatory infiltrate, lack of cytologic 
atypia in the latter. Likewise Adenosquamous carcinoma and Squamous 
cell carcinoma have true squamous differentiation with intercellular 
bridges or keratinization with surface and squamous dysplasia or 
carcinoma in situ. 
Cure is possible, especially for low-and intermediate-grade 
tumours. High profiferative index, vascular invasion, involved margins, 
and aneuploidy are also associated with a poor prognosis, Pires F R et al 
(2004); Handra Luca A et al (2005).  Treatment is wide local excision.  
Polymorphous low-grade adenocarcinoma (PLGA) 
It is characterized by infiltrative growth, morphologic diversity, 
and cytologic uniformity. Other designations include lobular carcinoma, 
terminal duct carcinoma and low-grade papillary adenocarcinoma. PLGA 
occurs almost exclusively in the minor salivary glands. Only rarely does 
it occur in the major glands, in that setting most often being the malignant 
component in carcinoma ex pleomorphic adenoma, Nagao T et al (2004). 
The commonest site of occurrence is the palate (60-70), followed by 
buccal mucosa (16%), upper lip (12%), retromolar area, base of tongue, 
Ellis G L et al (1996); Castle J T et al (1999). The peak age of 
presentation is in the fifth and sixth decades, but children can also be 
affected, Tsang Y W et al (1991) and there is a female predominance.    
Clinically the tumor presents as an asymptomatic mass with or 
without ulceration. Grossly circumscribed, nonencapsulated, pale yellow 
or tan mass of 1 to 3 cm. Microscopically solid nests, lobules, cribriform 
gland like structure or duct- like arrangements seen. Common feature is 
concentric whorling of cellular nests in a single file arrangement in a 
pattern “the eye of the storm”. The stromal hyalinization is characteristic 
and tumor cells are quite regular with moderate ecosinophilic  cytoplasm 
and characteristic round to oval nuclei with open chromatin. There is little 
mitotic activity and no necrosis and at the periphery  infiltrative growth 
and perineural invasion are common, Perez-Ordonez B et al (1998). 
A relatively diagnostic feature in PLGA is the targetoid pattern 
formed by concentrically arranged cords and narrow tubules of cells, 
reminiscent of sclerosing adenosis of the breast. A slate gray-blue stroma 
is said to be characteristic, Thompson LD (2004).  Dedifferentiated 
PLGA can rarely occur many years after the initial diagnosis or at 
presentation. Such lesions often resemble salivary duct carcinoma, 
Simpson RH et al (2002), with predominantly solid and cystic growth, 
high nuclear grade, and obvious tumor necrosis. 
The tumor cells show immunoreactivity for cytokeratin, EMA, and 
S-100 protein. A proportion of the tumor cells can express p63 in a 
haphazard distribution, Bilal H et al (2003). PLGA should be 
differentiated from Pleomorphic adenoma and Adenoid Cystic carcinoma. 
In Pleomorphic adenoma no infiltrative growth pattern or perineural 
invasion is  seen. There is positive staining for Gilial fibrillary acidic 
protein (GFAP) in a mesenchymal-like cell population adjacent to 
epithelial nests.  Adenoid Cystic carcinoma have basaloid cells with dark 
chromatin and little cytoplasm and the proliferative index is higher, 
Skalova A et al (1997). 
PLGA is a low-grade neoplasm, with more than 95% of patients 
being alive after a mean follow-up of 10 years, Castle JT (1999). Local 
recurrence and regional metastasis rates are 9-17% and 9-15% 
respectively, which may occur up to 14 years after initial treatment 
(mean, 7 years), Castle JT (1999); Evans HL et al (2000). Tumors with a 
predominant papillary configuration have been reported to carry a higher 
incidence of cervical lymph node metastasis, Evans HL et al (2000). 
Treatment is conservative resection.  
Acinic cell carcinoma 
It is a neoplasm demonstrating at least focal differentiation towards 
serous acinar cells. This neoplasm does not show myoepithelial 
participation. It contributes 1-3% of tumors and occur in pediatric to 
geriatric age from second to seventh decade of life. It is a second most 
common childhood malignancy. The most frequent sites of occurrence 
are the parotid gland (84%) and submandibular gland (4%), followed by 
the buccal mucosa, upper lip, and palate, Ellis GL et al (1996). It is the 
commonest malignant tumor that may present bilaterally (3%), Gnepp 
DR et al (1989). A slight female predominance is observed, and the mean 
age at presentation is 44 years. Acinic cell carcinoma has also been 
reported in antronasal mucosa, larynx, mandible, breast, lung, Lee HY et 
al (2003) and pancreas, Ohike N et al (2004). 
Acinic cell carcinoma typically presents as a slow-growing mass 
with or without pain. Facial nerve palsy is uncommon (5-10%), 
Colmenero C et al (1991); Ellis GL et al (1983).  This indolent tumor 
pursues a protracted clinical course, Ellis GL et al (1983). In a study of 65 
patients with long follow-up of up to 45 years, 44% of patients had local 
recurrence, 19% had metastasis and 25% died of disease, Lewis J et al 
(1991). Grossly there is a single, circumscribed solid mass which 
undergoes cystic degeneration. Microscopically it is highly variable that 
is solid, lobular, microcystic, papillary- cystic or follicular. Acinic cell 
look like salivary acinar cell with abundant, granular, basophilic 
cytoplasm and a small, round, eccentrically placed nucleus.   
PAS stain highlight the cytoplasmic zymogen granules resistant to 
diastase digestion and other cell types can also present are eosinophilic, 
clear, and vacuolated cells. There is dense lymphoid infiltrate (not in 
periphery of tumor). The nuclei are lined up in characteristic 
“regimented” rows. The finding of cytoplasmic vacuoles of variable sizes 
is highly characteristic of this tumor. Dedifferentiated acinic cell 
carcinoma is associated with rapid tumor growth, significant pain, facial 
nerve palsy, bulky tumor, and an extremely poor prognosis, Timon CI et 
al (2001).  
Most tumor cells exhibit immunohistochemical evidence of 
differentiation towards acinar cells and ductal cells, such as positivity for 
cytokeratin (especially low-molecular-weight cytokeratin), CEA. 
Differential Diagnosis it shoud be differentiated from Oncocytic 
carcinoma and Clear cell carcinoma which are  eosinophilic and  have 
clear cell type. The papillary variant of acinic cell carcinoma must be 
differentiated from Cystadenocarcinoma. 
Overall survival probabilities are 90% at 5 years, 83% at 10 years, 
and 67% at 20 years. Therefore lifelong follow-up is imperative, even 
after apparently complete excision, Lewis J et al (1991). Acinic cell 
carcinomas arising from the minor glands appear to be associated with a 
better prognosis, Ellis GL et al (1996). 
Frequent mitosis or high proliferative index, focal necrosis, neural 
invasion, gross invasion, desmoplasia, atypia and depletion of stromal 
lymphocytes have  been associated with more frequent recurrences and 
metastasis, Ellis GL et al (1996); Hamper K et al (1990); Lewis J et al 
(1991). Dense lymphoid stroma with well-developed germinal centers 
and showing a microcystic growth pattern throughout have a particularly 
favorable prognosis (no recurrence or metastasis on follow-up of 19 
months to 14 years), Michal M et al (1997).  Treatment of choice is 
complete surgical excision, supplemented by postoperative radiotherapy 
if the resection margin is involved. 
Adenoid Cystic Carcinoma 
It is an invasive neoplasm composed predominantly of basaloid 
cells with myoepithelial/basal cell differentiation, accompanied by 
interspersed ductal structures. It is characterized by cribriform, and /or 
solid patterns of growth and a myxohyaline stroma, Perzin KH et al 
(1978). Adenoid cystic carcinoma most commonly presents in the fourth 
to sixth decades, with a slight female predominance. The parotid gland, 
submandibular gland and palate are most commonly involved. This tumor 
has also been reported in lacrimal glands, auditory canal, upper 
respiratory tract, lung, digestive track, skin, breast, prostate and lower 
female genital tract, Lassaletta L et al (2003). 
It is a slow growing swelling and large tumors often cause fixation 
to skin or deeper tissues. There may also be tenderness, pain and facial 
nerve palsy due to the marked propensity of the tumor for neural 
invasion, Friedrich et al (2003). Palatal tumors often ulcerate and bone 
invasion may occur without radiographic changes as the tumor infiltrate 
through the marrow spaces. The tumor has often invaded well beyond the 
clinically apparent borders, Matsuba HM et al (1986); Nacimento AG et 
al (1986). It is a most recoganizable tumor and comprises 10% of salivary 
gland malignancies, the peak incidence occur between 40 to 60 years of 
age.  It is slow growing relentlessly progressive and perineural invasion is 
extremely common, so cranial nerve involvement, facial nerve palsy may 
be symptoms. Grossly solid, light tan, firm and well circumscribed.  
Microscopically, there are three type of growth patterns are seen 
cribriform, tubular, soild and mixed. Infiltrative growth is usually obvious 
on histologic examination, and perineural invasion is very common. The 
three characteristic growth patterns are present in variable combinations 
in an individual case.  In Tubular pattern double cell lined ducts are 
present. Solid type has only lobules of tumor cells without defined 
architecture. Solid growth pattern is rarely present in a pure form, and if 
so, may be extremely difficult to recognize, Batsakis J et al (1999). 
Cribriform  type is classic and most easily recognisable nests of cells 
arranged around gland – like spaces filled with PAS positive, granular 
basophilic material. Cells are basaloid with little cytoplasm and round to 
oval nuclei dark and hyperchromatic without nucleoli, quite regular with 
little mitotic activity (except solid type).  
In contrast to pleomorphic adenoma, there is no “melting” of the 
basaloid cells into the stroma. The stroma is fibrous with variable 
amounts of myxohyaline material rather than desmoplastic, and cartilage 
is not formed.Dedifferentiation of adenoid cystic carcinoma is associated 
with bulky disease, frequent local recurrence and metastasis, and rapidly 
fatal outcome, Nagao T et al (2003). 
Diagnosis and immunohistochemical staining confirms the 
predominant myoepithelial differentiation of the basaloid cells. These 
cells express cytokeratin, vimentin, S-100 protein (usually patchy 
staining), actin (variably), calponin, and p63, Emanuel P et al (2005) 
whereas the interspersed ductal epithelial cells express cytokeratin 
strongly, CEA and EMA.  
Low grade (tubular) tumor should be differentiated from 
Polymorphous low-grade adenocarcinoma, Epithelial-myoepithelial 
carcinoma and basal cell adenocarcinoma. All these three have no 
basaloid and hyperchromatic nuclei. Solid type high grade 
neuroendocrine carcinoma should be differentiated from Basaloid 
Squamous cell carcinoma which is bland appearing.  Tumor showing 
tubular and cribriform patterns represent lower-grade growths, Batsakis 
JG et al (1999); Batsakis JG et al (1990). The solid pattern is associated 
with large tumor size, earlier and more frequent recurrence, higher 
incidence of metastasis and earlier fatal outcome, Hamper K et al (1990). 
It is  found that carcinomas with significant solid areas (>30% of 
tumor area) have cumulative 5-year and 15-year survival rates of only 
14% and 5% respectively, compared with 92% and 39% for tumors 
without a significant solid component, Szanto PA et al (1984). Advanced 
clinical stage, location in a minor gland, large tumor size (>2-4cm), bone 
invasion, positive excision margins, non-diploid DNA content, high S-
phase fraction, and high Ki67 index have been reported to be poor 
prognostic factors, Hamper K et al (1990); Kokemueller H et al (2004). 
Long- term prognosis is poor. The 5-year survival is about 60-75%, 
but the 10-year survival drops dismally to 30-54%, Kokemuellur H et al 
(2004). The majority of affected patients (80-95%) eventually die of the 
disease after a protracted clinical course characterized by multiple local 
recurrences and metastasis, Hamper K et al (1990). Distant metastasis 
(most commonly lung, bone, and soft tissue) is more common than 
regional lymph node metastasis, and often occurs 5-10 years after initial 
treatment, Rapidis AD et al (2005).  Radical excision is the treatment of 
choice and benefit of radio therapy remains unproven, Friedrich RE et al 
(2003); Kokemueller H et al (2004). 
Malignent mixed tumor  
(i)True salivary gland malignant mixed tumor (carcinosarcoma) 
It composed of both carcinomatous and sarcomatous components 
and 2/3 tumour arise from parotid gland, 15% submandibular gland and 
15% from palate. It is a very aggressive tumor and 1/3 die within 30 
month of time. Occurence of this tumour is very rare and the mean age at 
presentation is 62 years with no sex predilection. The tumor most 
frequently affects the major salivary glands. In one-third of cases, there is 
clinical or histologic evidence of coexisting pleomorphic adenoma, Kwon 
MY et al (2001).  
Grossly the tumour is firm, tan-white mass with hemorrhage, 
necrosis  occasionally with grittiness or calcification. Microscopically 
there is intimate mixture of two components that is malignant epithelial 
and mesenchymal elements. The epithelial component is most often a 
squamous cell carcinoma or adenocarcinoma and the most common 
malignant mesenchymal component is chondro sarcoma, followed by 
fibrosarcoma, leiomyosarcoma, osteosarcoma, liposarcoma, and 
rhabdomyosarcoma, Kwon MY et al (2001); Gnepp DR (1993). It is an 
aggressive tumor with a mean survival of only 29.3 months, Gnepp DR 
(1993).  Treatment is wide local excision with radiotherapy. 
(ii) Carcinoma ex pleomorphic adenoma 
Carcinoma ex pleomorphic adenoma represents malignant 
transformation of a pre-existing pleomorphic adenoma usually in the 
setting of long-standing pleomorphic adenoma or in a tumor with 
multiple recurrences. The incidence ranges from 1.9% to 23.3% (mean 
6.2%) according to different series, Auclair PL et al (1996).  It occures 
mostly in parotid gland and during  sixth to seventh decade of life. Long 
standing mass undergo rapid growth over a period of several months is a 
classic history of this tumour. The risk increases with the duration of the 
tumor, with an incidence of 1.6% for tumors presenting for less than 5 
years, increasing to 9.5% for tumors presenting for more than 15 years, 
Eneroth CM et al (1974). 
The tumor is usually larger than its benign counterpart. Grossly the 
tumour may be up to 25cm and carcinomatous component is infiltrative, 
hard, white to gray mass with hemorrhage and necrosis. Malignant 
transformation is heralded by rapid growth after a long period of a 
minimally perceptible increase in size. Signs of malignancy also include 
fixation to surrounding tissues, ulceration, facial nerve palsy, and regional 
lymphadenopathy. The mean age at presentation is 61 years, about one 
decade older than that of pleomorphic adenoma, Lewis JE et al (2001); 
Ellis GL et al (1996).   
Histologically, the malignant component is characterized by 
widespread significant cellular pleomorphism, a high mitotic count, 
atypical mitotic figures, coagulative necrosis and the presence of an 
expansile or infiltrative nodule within the parent adenoma.   In most 
cases, the malignant component dominates the tumor, and is most 
frequently a high-grade carcinoma (85% of cases) such as 
adenocarcinoma NOS or salivary duct carcinoma but sometimes maybe 
adenosquamous carcinoma, undifferentiated carcinoma, or sarcomatoid 
carcinoma. Low-grade carcinomas such as PLGA, adenoid cystic 
carcinoma, mucoepidermoid carcinoma, epithelial myoepithelial 
carcinoma and myoepithelial carcinoma can also occur infrequently, 
Lewis JE et al (2001); Ellis GL et al (1996). 
The most important prognostic factor is the extent of extra capsular 
invasion. Carcinoma in situ and intracapsular carcinoma have no 
metastatic potential, Lewis JE et al (2001). In several large series, 
excellent prognosis has been found in tumors with extracapsular invasion 
less than 8mm, Tortoledo ME et al (1984) 5mm, Lewis JE et al (2001) 
beyond the capsule respectively. Poor outcome has been found to be 
associated with: (1) high histologic grade of malignant component         
(5-year survival 30% versus 96% for low histologic grade); (2) high 
pathologic stage; and (3) proportion of carcinoma more than 50% of the 
tumor, Lewis JE et al (2001); Tortoledo ME et al (1984). Most patients 
develop recurrence and metastasis, and the overall 5-year survival is only 
30%, Lewis JE et al (2001).  Treatment is wide resection and radiation for 
widely invasive tumors. If cervical lymphnode metastasis is present 
lymph node dissection should also be done. 
(iii) Metastasizing mixed tumor 
Metastasizing pleomorphic adenoma is a rare complication of 
pleomorphic adenoma. Generally, metastasis occur after a relatively long 
period. Rarely, the metastatic tumor may represent the initial  
manifestation of an occult plemorphic adenoma in the salivary gland, 
Czader M et al (2000). 
The disease apparently pursues a more rapidly aggressive course in 
immunocompromised hosts, Sampson BA et al (1998). Malignant 
transformation of metastatic pleomorphic adenoma has also been 
reported, Fujimura M et al (1997).  Vascular permeation secondary to 
mechanical implantation has been postulated as a probable mechanism 
for the development of metastasis, Hoorweg JJ et al (1998). Treatment is 
local excision of both the primary and metastatic tumors. Recur at 
primary site and the mortality rate is 40%. 
Salivary duct carcinoma  
 Salivary duct carcinoma is an aggressive malignant tumor 
morphologically reminiscent of ductal carcinoma of the breast. It can 
occur de novo or as the malignant component in carcinoma ex 
pleomorphic adenoma, Delgado R et al (1993); Jaehne M et al (2005). 
Salivary duct carcinoma most frequently affects the elderly (peak 
incidence in the sixth and seventh decades), with a male to female ration 
of 3-6:1. The parotid gland accounts for 80% of cases and the rest arise in 
the submandibular gland, and rarely, minor glands of the oral cavity. The 
patients commonly present with a rapidly enlarging parotid mass 
associated with facial nerve palsy (42%), pain  (23%) and cervical 
lymphadenopathy ( 35%), Lewis JE et al (1996).  
Grossly there is poorly circumscribed, predominantly solid, and 
tan-colored. There are often foci of necrosis. Gross extension of tumor 
beyond the salivary gland is noted in about 70% of cases, Lewis JE et al 
(1996). Microscopically cribriform pattern similar to breast ductal 
carcinoma with comedo-type necrosis and invasive component consist of 
large cells with abundant eosinophilic cytoplasm and large, round nuclei 
with vesicular chromatin and prominent nucleoli. Marked tissue 
infiltration with stromal desmoplasia and brisk mitotic activity and 
vascular and perineural invasion are common, Barnes L et al (1994).  
Diagnosis by luminal epithelial nature of the tumor cells, with 
diffuse strong staining for cytokeratin, EMA, and CEA. Almost all cases 
express androgen receptor, which is a characteristic, although not 
specific, feature of this salivary gland carcinoma, Nasser SM et al (2003). 
It should be differentiated from metastatic breast carcinoma which is 
positives for estrogen/ progesterone receptor, and negative for androgen 
receptor. Also differentiated from Mucoepidermoid carcinoma which 
have mixture of cell types such as epidermoid cells and goblet cells and 
intraductal carcinoma which is primary salivary duct carcinoma than 
metastasis. Oncocytic carcinoma is characterized by large tumor cells 
with granular eosinophilic cytoplasm filled with mitochondria. Both 
oncocytic carcinoma and cystadenocarcinoma lack the comedo necrosis 
and intraductal-like pattern typically seen in salivary duct carcinoma.  
This is one of the most aggressive salivary gland carcinomas. The 
tumor mortality can be as high as 77% at a mean follow up of 3 years, 
Lewis JE et al (1996). Local recurrence occurs in 35-66% of patients, 
lymph node metastasis in 66% and distant metastasis in 50-70%, Lewis 
JE et al (1996); Guzzo M et al (1997). The most frequent sites of distant 
metastasis are the lung, bone, and brain and with 65% of mortality. 
Treatment is wide local excision with neck dissection and postoperative 
radiotherapy.  
Epithelial – Myoepithelial carcinoma 
Composed of ductal structures lined by a single layer of ductal 
cells which are surrounded by a single or multiple layers of clear 
myoepithelial cells. The counterpart in the breast is 
adenomyoepithelioma, Seifert G (1998). It is a low grade tumor and 
accounts for 0.5 to 1%. The peak incidence is in the sixth and seventh 
decades, with a slight female predominance. Approximately 60% of cases 
occur within the parotid gland, while submandibular gland and intraoral 
minor salivary gland are responsible for the rest. Most patients present 
with an asymptomatic mass, and a minority of patients have pain and 
facial weakness. The tumor has also been reported to occur in lacrimal 
gland, lung, bronchus, trachea, nasal cavity, nasopharynx and liver, Ru K 
et al (2004); Doganay L et al (2003).  
Grossly the tumour is firm and well-demarcated with 2-cm 
diameter. It will  be partially encapsulated, with invasion into adjacent 
parenchyma. Microscopically classic morphology is ductal structures 
lined by eosinophilic cells with a prominent supporting layer of clear 
myoepithelial cells, myoepithelium present as large sheets of cells with 
only focal ductal differentiation. The stroma between tumor nests is 
eosinophilic and hyalinized, individual tumor cells are bland with 
minimal mitotic activity. The prototypic bicellular architecture consists of 
a tubular structure lined by ductal cells, surrounded by one or several 
layers of clear cells, which are further enveloped on the outside by a well-
defined basement membrane. The tubular luminal cells are cubodial, with 
round, bland- looking nuclei and a moderate amount of pink cytoplasm, 
reminiscent of intercalated duct cells. Rarely, there can be squamous 
differentiation. The clear cells are polygonal, considerably larger in size 
and have abundant water-clear cytoplasm. The cytoplasmic clearing is 
due to accumulation of glycogen. These cells exhibit a myoepithelial 
immunophenotype and ultrastructural features.  
Immunohistochemically, the duct- lining cells are positive for  
cytokeratins and myoepithelial cells are positive for calponin, smooth 
muscle actin and p63, Alos L et al (1999).  It should be differentiated from 
Pleomorphic adenoma myoepithelioma/Myoepithelial carcinoma which 
do not have myoepithelial differentiation. Also differentiated from 
tubular variant (Grade I) adenoid cystic carcinoma which have no clear 
cells, if present very focal. There is cribriform structures and light 
basophilic mucosubtance in microcystic spaces. 
Epithelial-myoepithelial carcinoma is a relatively low-grade 
malignancy. Recurrence is reported in 30-40% of cases, which may occur 
as long as 28 years after initial surgery. Regional lymph node metastasis 
occurs in 10-20% of cases, but distant metastasis (lung, kidney and brain) 
is uncommon (90%). Tumor-associated mortality is low (0-90%), Luna 
MA et al (1987).  Also reported that tumors with more than 20% of cells 
showing nuclear atypia are associated with a poorer prognosis, Fonseca I 
et al (1993). Treatment is wide local excision with or without 
radiotherapy.  
Squamous cell carcinoma 
This tumor mainly affects males, with a mean age of 64 years, 
Prior radiation therapy for acne, benign and malignant tumors, enlarged 
thymus, thyroid gland and tonsils have been implicated as predisposing 
factors in some cases, Ellis GL et al (1996). It is a aggressive tumour, 
rarely primary and is metastasis to intraparotid lympnode from primary 
skin cancer of head and neck (scalp, ear and face). It occurs during sixth 
to eighth decade of life and seen in 80% parotid, 20% in submandibular 
gland. 
Grossly firm, white, infiltrative and nonencapsulated mass. 
Histologically it is usually a moderately to well – differentiated squamous 
cell carcinoma consisting of sheets and islands of squamous cells with 
readily identifiable keratin formation and intercellular bridges. There is 
prominent desmoplasia and Perineural invasion into periglandular soft 
tissue is frequently present. 
It should be differentiated from metastatic squamous cell 
carcinoma and also from high grade mucoepidermoid carcinoma which is 
largely squamoid appearance but lack keratinization, more heterogenous 
cell population and always demonstrates mucous cells. Ulceration, 
fixation, advanced patient age, advanced tumor stage and facial nerver 
palsy are unfavorable prognostic factors, Gaughan R et al (1992). The 5-
year survival rate is only around 30%. Treatment is radical surgery, neck 
dissection and radiotherapy. Squamous cell carcinoma tends to invade 
and spread rapidly. Since cervical lymph node metastasis is common, 
routine radical neck dissection may be advisable. 
Adenocarcinoma 
It is a rare, but aggressive tumour. It occurs above 40 years of age 
and mostly parotid and minor salivary gland are affected. Clinically 25% 
complain of pain or facial weakness.  Grossly firm mass with irregular 
border and infiltration into surrounding tissue. It is a solid tumour without 
cystic spaces. Formation of glandular structures are divided in to Grade I 
to IV. Grade I is well formed ductal structures and II is more solid growth 
pattern with few glandular characteristics. Treatment is complete local 
excision and metastasis  is common. The recurrence rate is 51%. 
Clear cell carcinoma 
 Also called as glycogen rich carcinoma. It is a rare tumour and 
occur in palate & parotid gland. It is seen between sixth to eighth decade 
of life.  Microscopically uniform round polygonal cells with peripherally 
displaced dark nuclei and clear cytoplasm was seen. Tumor cell grow in 
nests or cords separated by fibrous stroma or solid sheets of cells. Local 
infiltrative growth is characteristic of this tumour. Treatment is complete 
local excision. 
Pediatric tumors 
These are uncommon tumours. There are two congenital tumors  
reported.  
(i) Sialoblastoma 
It is rare, aggressive tumor and occur at embryonic stage. It 
develop from blastomatous cells and seen in perinatal to neonatal period 
and mostly in parotid gland. Grossly, it is lobulated and partially 
circumscribed. Microscopically nests or nodules of basaloid cells are seen 
with scanty cytoplasm, round to oval nuclei, and fine chromatin with 
small nucleoli. Treatment is complete surgical excision with a rim of 
normal tissue. 
(ii) Salivary anlage tumor (Congenital pleomorphic adenoma) 
It occurs in male neonates in first 2 weeks of age. The tumour mass 
attached by thin stalk to posterior nasal mucosa or nasopharynx. Grossly 
firm & tan yellow with smooth surface. Microscopically nonkeratinizing 
squamous epithelium, with deep stroma composed of bland spindled cells 
and intervening squamous is lands suggests a hamartoma. Treatment is 
simple excision. 
Metastasis to the salivary gland 
Metastasis to the salivary gland from intra or periglandular was 
lymph nodes are common. For parotid gland usually head and neck 
primary tumor. Skin tumors such as squamous cell carinoma and 
melanoma accound for 80% of metastasis. 85% of submandibular gland 
metastasis are from non head and neck tumors, from infraclavicular areas 
scommonly breast, kidney and lung (small cell carcinoma of the lung). 
MATERIALS AND METHODS 
This study included salivary gland biopsy specimens submitted for 
histopathological study to the Department of Pathology, Tirunelveli 
Medical College from 2006 to 2010.  The demographic data regarding 
age, gender, location of lesion, duration, associated symptoms were 
recorded in a proforma.  
Detailed gross  examination was done and the findings were 
recorded. 
4 micron sections were cut and stained with routine haematoxylin 
and eosin stains. Based on the histopathology, the lesions were 
categorized into neoplastic and non neoplastic lesions.  The neoplastic 
lesions were further divided into benign and malignant types.  The 
malignant tumor were further typed histologically into various categories.  
Special stains like Periodic acid Schiff (PAS), Alcian blue and 
Phosphotungstic acid stain also done. 
Haematoxylin and Eosin staining  
1. Xylene, three changes…..  2minutes each 
2. Absolute alcohol…..   10 dips 
3. 90% alcohol, 80% alcohol,  
and 70% alcohol……   10 dips each 
4. Tap water…. rinse until water runs off evenly 
5. Haematoxylin,…..    15 minutes 
6. Tap water, two changes ……  10 dips each  
7. Lithium carbonate, 0.5% ….  Until blue 
8. Tap water, two changes…..  10 dips each  
9. Eosin …….     10 to 20 dips 
10. 70% alcohol, 80% alcohol and  
90% alcohol ……    10 dips each 
11. Absolute alcohol, three changes… 10 dips each 
12. Xylene, three changes…..  10 dips each 
13. Mount the slide in D.P.X 
Periodic Acid Schiff (PAS) staining 
1. Cut paraffin sections ate 4 to 5 microns thick  
2. Deparaffinize and hydrate slides to distilled water. 
3. Wash slides in three changes of distilled water. 
4. Place the section in Periodic acid for 5 minutes. 
5. Water wash for 1 minute. 
6. Place sections in Schiff reagent for 15 minutes. 
7. Wash for 1 minute in each of two jars of 0.55% potassium 
Metabisulfite to remove excess stain. 
8. Wash in running tap water for 10 minutes to develop full color. 
9. Counterstain ½ minute in Harris’ hematoxylin with acetic acid 
(2ml acetic acid/48 ml haematoxylin) 
10. Wash sections well to blue the haematoxylin. 
11. Dehydrate with 95% and absolute alcohol, clear with Xylene and 
mount the section. 
Alcian Blue Staining   
1. Cut paraffin sections at 4 to 5 micron thickness 
2. Deparaffinize and hydrate sections to distilled water. 
3. Place slides in 3% acetic acid solution for 3 minutes. 
4. Place slides in alcian blue solution for 30 minutes. 
5. Wash slides in running tap water for  10 minutes. 
6. Rinse in distilled water. 
7. Counterstain in nuclear fast red solution for 5 minutes. 
8. Wash in running tap water for at least 1 minute. 
9. Dehydrate in two changes each of 95% alcohol and absolute 
alcohol and clear in Xylene. 
10. Mounting. 
Phosphotungstic acid Staining 
1. Deparaffinize, hydrate through graded alcohols to water. 
2. Place in acid dichromate solution for 1 minute. 
3. Wash in tap water. 
4. Treat with acid permanganate solution for 1 minute. 
5. Wash in tap water. 
6. Bleach in 1% oxalic acid. 
7. Rinse in tap water. 
8. Stain in Mallory’s PTAH stain overnight. 
9. Dehydrate through graded alcohols, clear and mount. 
Special stains for various neoplasms 
Neoplasm Special Stain 
Pleomorphic adenoma     Alcian blue  
 Acinic cell carcinoma   Periodic Acid Schiff 
Mucoepidermoid carcinoma  Periodic Acid Schiff 
Adenoid cystic carcinoma Periodic Acid Schiff 
Oncocytoma  Phospho  tungstic acid hematoxilin   
 
The results were analyzed, tabulated as percentage proportion and 
compared with the existing literature.   
RESULTS 
There was totally 80 salivary gland lesions from both outpatient 
and inpatient during the 5 year period between 2006 to 2010.  The age of 
occurrence was from 10 years to a maximum of 80 years with mean age 
of 41.19 years. Of these, 32.5% in males and 67.5% in females. The 
distribution of lesion was 71.25% in parotid, 25% in submandibular 
gland, 2.5% in accessary gland and 1.25% in sublingual gland. 
Out of the 80, there were 17 (21.25%) non neoplastic with mean 
age 38.51 and 63 (78.75%) neoplastic lesions with mean age of 41.89. Of 
the non neoplastic lesions 16 (94%) were sialadenitis and 1 (5.87%) was 
sialolith. Among neoplastic lesions 50(79.4%) was benign and 13 
(20.6%) was malignant. Most common benign tumour was pleomorphic 
adenoma 42(84%) and most malignant tumour was mucoepidermoid 
carcinoma 3(23%) and acinic cell carcinoma 3(23%). The distribution  of 
salivary gland lesion is given in graph-1 and sex distribution in Table.1 
Sialadenitis seen in the age group of 15 to 56 years and 62.5% of 
cases occurred in 30-50 years of age. The mean age was 38 years. It 
involves 10(62.5%) of females  and 6(37.5%) males. Out of the 16, 11 
(68.75%) was seen in submandibular and 5(31.25%)was seen in parotid 
gland.   Sialadenitis show statistical significant difference in relation to 
age, sex and occurrence in parotid gland.  There is no significant  
difference in relation to occurrence in submandibular gland.  One case of 
sialolith was recorded in a female at the age of 48 in submandibular 
gland.   
 Salivary gland tumours recorded were 63 (78.75%) cases.  It 
occurred between 10 to 80 years of age and 76.19% of tumours occurred 
at the age group of 20-60 years.  Among benign tumours peak incidence 
of 24% was recorded in 2nd and 3rd decades followed by 20% in 4th 
decade.  In malignant tumours 23% occurred at 5th decade followed by 
15.3% in 2nd to 7th decades of life. 
      It was seen 31.75% in males and 68.25% in females with a male 
female ratio of 1:2.15.   Among this benign was 50 (79.3%) with male 
female ratio of 1.5:2.65 and mean age of 40.18.  Malignant was 13 
(20.6%) with male female ratio of 1:5.5 and mean age of 48.46.  Largest 
number of tumours occurred in parotid gland 52(82.5%), followed by 
submandibular 8 (12.7%) then accessary gland 2(3.17%) and sublingual 
gland 1(1.59%).  Salivary gland tumour shows statistical significant 
difference in relation to sex, age and occurrence in salivary gland except 
age wise distribution of malignant salivary gland tumour.  Different type 
of tumours recorded were given in Table-2. 
  The most predominant neoplasm was Pleomorphic adenoma with 
42 (66.66%) out of 63 total neoplasms and with the peak occurrence in 3rd 
 decade 10 (23.8%) followed by 2nd and 4th decade with 9 (21.4%).  Male 
female ratio was 1:1.625.  Most tumour occurred in parotid 36 (85.7%) 
followed by submandibular 4 (9.5%) then sublingual 1 (2.38%) and 
accessory gland 1 (2.38%).  Pleomorphic adenoma shows statistical 
significant difference in relation to sex, age and salivary gland.  
Prevalence among male female sexes and age wise distribution are given 
in graph-3. 
The second most common neoplasm was Mucoepidermoid 
carcinoma and Acinic cell carcinoma with 3 cases each (4.76%) out of 63 
total neoplasms.  It was seen only in parotid gland with male female ratio 
of 1:2.  It was seen between second to seventh decade of life. 
Two cases each (3.17%) recorded were Warthin’s tumour, 
Myoepithelioma with cyst, Benign lymphoepithelial cyst, 
Adenocarcinoma.  One cases each (1.58%) recorded were Basal cell 
adenoma, Monomorphic adenoma, Squamous cell carcinoma, Epithelial-
Myoepithelial carcinoma, Adenoid cystic carcinoma, Adenosquamous 
carcinoma, Malignant oncocytoma. 
 
 
 
Table-1 
Sex wise distribution of Salivary gland lesions 
S.No Lesion Male Female Total 
I Non neoplastic    
 (a) Sialadenitis   6 10 16 (20%) 
 (b) Sialolithiasis  - 1 1 (1.25%) 
 Total 6 11 17(21.25%) 
II Neoplastic    
 Benign    
 (a) Pleomorphic adenoma 16 26 42(52.5%) 
 (b) Benign lymphoepithelial cyst - 2 2(2.5%) 
 (c) Myoepithelioma  1 1 2(2.5%) 
 (d) Warthin’s tumour 1 1 2(2.5%) 
 (e) Basal cell adenoma - 1 1(1.25%) 
 (f) Monomorphic adenoma - 1 1(1.25%) 
 Malignant    
  (a) Mucoepidermoid carcinoma 1 2 3 (3.75%) 
  (b) Acinic cell carcinoma 1 2 3 (3.75%) 
 (c) Adenocarcinoma  - 2 2(2.5%) 
 (d) Squamous cell carcinoma - 1 1(1.25%) 
 (e) Epithelial‐Myoepithelial carcinoma - 1 1(1.25%) 
 (f) Adenoid cystic carcinoma - 1 1(1.25%) 
 (g) Adenosquamous carcinoma - 1 1(1.25%) 
 (h) Malignant oncocytoma - 1 1(1.25%) 
 Total 20 43 63(78.75%) 
  
 
Table -2 
Different type of  neoplasms recorded 
Benign No. of cases Percentage 
(a) Pleomorphic adenoma 42 66.6% 
(b) Benign lympho epithelial cyst 2 3.17% 
(c) Myoepithelioma  2 3.17% 
(d) Warthin’s tumour 2 3.17% 
(e) Basal cell adenoma 1 1.59% 
(f) Monomorphic adenoma 1 1.59% 
Total 50 79.37% 
Malignant   
 (a) Mucoepidermoid carcinoma 3 4.76% 
(b) Acinic cell carcinoma 3 4.76% 
(c) Adenocarcinoma 2 3.17% 
(d) Squamous cell carcinoma 1 1.59% 
(e)Epithelial-Myoepithelial carcinoma 1 1.59% 
(f) Adenoid cystic carcinoma 1 1.59% 
(g) Adenosquamous carcinoma 1 1.59% 
(h) Malignant oncocytoma 1 1.59% 
Total 13 20.63% 
 
  
 
 
Table-3  Age wise distribution of different neoplasm types 
Neoplasm Age 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80-89 Total 
Pleomorphic adenoma 3 9 10 9 5 3 2 1 42 
Benign lymphoepithelial cyst  2       2 
Myoepithelioma with cyst   1 1     2 
Warthin’s tumour  1    1   2 
Basal cell adenoma      1   1 
Monomorphic adenoma    1      1 
Mucoepidermoid carcinoma  1  1  1   3 
Acinic cell carcinoma  1   1  1  3 
Adeno carcinoma     2    2 
Squamous cell carcinoma      1   1 
Epithelial-Myoepithelial carcinoma    1     1 
Adenoid cystic carcinoma   1      1 
Adenosquamous carcinoma   1      1 
Malignant oncocytoma       1  1 
Total  3 14 14 12 8 7 4 1 63 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1 : 
Photomicrograph of Warthin’s tumour [ HE, x100] 
 
 
 
Fig 2 : Pleomorphic Adenoma Parotid   { HE, x100] 
 
 
 
 
Fig 3 ; Microcystic Pattern of Basal cell adenoma  [ HE, x100] 
 
 
 
Fig 4 : Photomicrograph of Benign Lymphoepithelial Cyst [HE,x40] 
 
 
 
 
Fig 5 : Photomicrograph of Chronic Sialadenitis [HE, x100] 
 
 
 
Fig 6 :  Mucoepidermoid carcinoma ,mucoid areas [HE, x100] 
 
 
 
 
 
Fig 7 : Mucoepidermoid carcinoma, high grade epidermoid area 
[ HE,x400] 
 
 
Fig 8 : Primary Keratnizing Squamous cell carcinoma [HE, x100] 
 
 
 
 
Fig 9 : Malignant Oncocytoma [ HE, x100] 
 
 
 
Fig 10 : Epithelial – Myoepithelial carcinoma [ HE, x400] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 11 : Adenocarcinoma NOS type [ HE, x100] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 12 ; Adenoid cystic carcinoma salivary gland [ HE, x100] 
 Fig 13 : Myoepithelioma Spindle cell type (HE X 100)  
Fig 14 : Myoepithelioma plasma cell type (HE X 100)  
 
 
Fig 15 : Pleomorphic adenoma (Alcian blue X100)  
Fig 16 : Mucoepidermoid carcinoma (PAS X 100)  
 
 
Fig 17 : Oncocytic carcinoma (PTAH X 400)  
Fig 18 : Acinic cell Tumour (PAS X 40)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Fig 19 : Adenoid Cystic Carcinoma (PAS-100X) 
DISCUSSION 
This study broadly  analyzed    the pattern of salivary  gland lesions 
presented to this tertiary  care center over a  period of 5 years from 2006 
to 2010. The lesions were classified into non-neoplastic and neoplastic 
and correlation was done with the demographic  data collected along with 
the biopsy request . 
Type of lesions  
Neoplastic lesions were more common than non-neoplastic lesions. 
We had 63 (78.75%) neoplastic  lesions and 17 (21.25%) non-neoplastic 
lesions. This observation is similar to that of Jeyaram et al loc.cit (2001) 
where they have recorded neoplasm in 74.5% of their cases and the non- 
neoplastic lesions contributed to 25.5%. A similar study from eastern part 
of India by Bandhopadhyay et al loc.cit (2005) had reported 53.4% of 
salivary gland neoplasam and 40.5% of non-neoplastic lesions. 
Age   
The mean age of presentation of the salivary gland lesions was 
seen at fourth  decade of life. The mean age was 41.9 in our study. This is 
almost similar to the observation of Nagarkar et al loc.cit (2004) and 
Jeyaram et al loc.cit(2001). 
Gender 
In our study we had a total of 54 (67.5%) female patients and 26 
(32.5%) male patients. This is very similar to the data reported in the 
literature that lesions of the salivary gland are more common in women 
gender. Our data correlates very well with the data of Ansari et al (2007) 
who had observed lesion in 60% of women and men contributed to 40%. 
The data was also very similar to that of de Oliveira et al  (2009) study in 
which females were 61% and men 39%. 
In few studies like that of Ladeinde et al (2007) men outnumbered  
women . A similar observation was given by Li et al (2008) who 
observed 53.5% lesion in men and the rest 46.5% in women. 
Our results correlated with the observations of authors like Musani 
et al (2008) and Satko et al (2000). 
Analysis of non- neoplastic lesions  
We had a total of 17 cases with diagnosis of non-neoplastic 
conditions. The most common of them was sialadenitis (16 cases) and a 
single case with sialolithiasis. Again a female preponderance of the 
lesions were observed with 11 female patients to 6 male patients. 
Sialadenitis 
Analysis of the cases with sialadenitis, the most common pattern 
was that of chronic non specific sialadenitis with mild lymphocytic 
infiltration of the acinar structures of major salivary gland. The other 
more consistent observations were parenchymal atrophy, which we saw 
in 10 of our cases, similar to the observation of Harrison et al (1997) and 
we had fibrosis in 2 of our cases akin to the findings of Kurashima et al 
(1986). 
Seifert G (1997) found that most of the cases reported on chronic 
sialadenitis have a high statistical association with rheumatoid arthritis 
and he attributed an immunological cause for that. 
Out of the 16 cases, we had significant history of rheumatoid 
arthritis in 5 cases, of which one had positivity for serum Rheumatoid 
Arthritis factor(RA factor ). 
Further sub typing of the lesions reported as chronic sialadenitis, 
we had a single case of chronic granulomatous sialadenitis and another 
case of chronic xantho –granulomatous  sialadenitis. The most common 
causes attributed to the granulomatous tissue response are tuberculosis,  
sarcoidosis, duct obstruction due to calculi and extravasation of mucin in 
tumors. In both of our case we did not find any specific etiological factor 
attributed towards granuloma.  
Sialolithiasis 
According to Lutcavage et al (1991) calculi may form in the major 
ducts of submaxillary sublingual and parotid glands. They may be 
bilateral and multicenteric. In our study we had a single case present with 
calculi in the submadibular gland. This correlates well with the 
observations of Husted (1953), who found out that calculi are more 
common in submandibular gland as the  saliva is more concentrated with 
calcium salts. Microscopically there was dilation of the duct with 
moderate chronic inflammation and a foci with squamous metaplasia.  
Analysis of neoplastic lesions 
Benign tumors 
We had 50 cases (79.3%) of  benign  salivary gland tumors out of 
total 63 cases, which correlates very well with the literature  that in 
salivary glands benign tumor  out number malignant.  
Pleomorphic adenoma 
Of the total benign tumors, the most common was pleomorphic  
adenoma 42 cases (84%). It contributed 84% of total benign tumor and 
52.5% of all salivary gland tumors. This observation correlates well with 
that of Seifert et al (1986) and Spiro RH (1986) who observed a 
percentage varying from 45-74%. Another study from AFIP states that 
the pleomorphic adenoma accounts for more than 78% of all the benign 
tumors of salivary gland which is very close to our study, Woods JE et al 
(1975).  
The most common site of presentation was the parotid gland. Out 
of the total 42 cases 30 was located in the parotid (71.4%), followed by 
submandibular gland 7 case  (16.6%) and the rest were from intraoral 
minor salivary glands. This is very similar to the observation of the 
Waldron et al (1988). 
Regarding the age distribution more than 50% of our cases 
occurred under the age of 50  (31 case out of 42). Eveson et al (1985) had 
a similar observation in which the mean age of the patients was 43. 
Regarding the location of the tumor, in most of our cases the tumors was 
located in the lower pole of the superficial lobe of the gland. None of our 
cases presented with facial paralysis. The cut surface of the mass was 
generally  homogenous, tan to white and in four case, tiny foci of 
hemorrhagic area were seen probably  due to fine needle aspiration 
cytology and in 2 cases abundant myxoid areas were seen grossly. 
Out of the 42 cases reported as pleomorphic adenoma , we had 10 
cases with predominant myxoid  component and 4 cases with epithelium 
predominant areas. This is very similar to the observations of Seifert G et 
al (1986), who found that 12-15% of pleomorphic adenomas have 
epithelial component that constitutes more than 80% of the tumor. The 
epithelial cell component was predominates  cuboidal with few cases 
showing spindle cells and basaloid cells. The mesenchymal element was 
mostly myxoid and hyaline with chondroid areas. We had 2 cases with 
focal osseous areas. 
Myoepithelioma 
Regarding other benign tumors we had a two cases of 
myoepithelioma, which was categorized into the plasmacytoid variant 
and spindle cell variant respectively. Both the lesions were from the 
parotid gland. The spindle cell variant was cellular with minimal stromal 
component whereas the plasmacytoid variant was less cellular with 
loosely cohesive plasmacytoid cells in a  mucoid  stroma. This case also 
had remarkable cystic degeneration . 
Warthin’s tumor 
Warthin’s tumor was reported in 2 of our cases, consisting 2.5% of 
the salivary gland tumors. This value is below the observation of Spiro et 
al loc.cit (1986) who found 4 to 11.2% incidence in their series. Both the 
cases occurred in parotid  salivary gland. The  usual male/female ratio is 
26:1 Li WY  and Liu HC (1987), 5:1  Chaudry AP and  Gorlin R (1958). 
But we had  a young women presenting with a cystic lesion of parotid, 
which turned out to be a case of warthin’s tumor. Recent studies claim a 
marked reduction in the male predilection to 1.1:1 and 1.6:1, Lamelas J et 
al (1987). In both, the clinical feature was a painless fluctuant swelling in 
the parotid.  
Basal cell adenoma 
We had a single case of basal cell adenoma in a 65 year old female 
patient. It constituted 2% of total benign tumor and 1.2% of all salivary 
gland tumors in our study. This is  equivalent to the observation of Ellis 
GL et al(1996), who recorded an incidence of 1% to 4% of all primary 
salivary gland tumor. It has been recorded that they predominantly (more 
then 75%) occur in the parotids and is common in elderly women. In our 
study the patient was an elderly female with a small nodule is the parotid. 
The tumor was composed of uniform small cells with pale eosinophilic 
cytoplasm and uniform round to oval nuclei. Our case was categorized 
into the solid variant of basal cell adenoma.  
 
 
Canalicular adenoma 
We had a single case of canalicular adenoma reported  in a 37 year 
old female patient presenting with a parotid nodule. Canalicular adenoma 
is usually seen in  minor  salivary glands and they constitute 4-6% of all 
tumors of  minors salivary gland, Waldron et al loc.cit (1988). It usually 
occurs in elderly women with peak incidence in the seventh decade of 
life. It is uncommon  in patients under  50 years. But in our study we had 
a younger patient presenting as canalicular adenoma in a major salivary 
gland. We had 2 cases of benign lymphoepithelial cysts of the  parotid 
gland. Ellis GL and Auclair PL (1996) have reported an incidence of 2-
3% of all parotid surgical specimens. In our study it contributed to 2.5% 
of the total cases.  
The diagnosis was established by the presence of dense lymphoid 
tissue with conspicuous germinal centers in the wall of the cyst. 
Malignant tumors 
We had 13 cases of malignant lesions of salivary gland reported. 
We had 3 cases of mucoepidermoid  carcinoma and 3 cases of acinic  cell 
carcinoma (Ref.  Table – 1). 
Mucoepidermoid carcinoma 
Mucoepidermoid  carcinoma is the most common malignant 
salivary gland tumor. It represents about 22 % of the malignant tumors of 
major salivary gland, Spiro RH et at (1978). In our series, it contributes to 
23% of all malignant tumors. All of them occurred in parotid with female 
preponderance. In all the three it present as a solitary painless mass of the 
parotid .  Microscopically  the tumor consist of mucous,  epidermoid, 
intermediate, columnar and clean cells in both solid and cystic 
configurations. In most of the cases the mucus cells comprise less than 
10%. One of our case had intraluminal  papillary proliferation of the 
mucus cells. A similar observation was made by Auclair PL et al (1992).  
   Mucoepidermoid carcinoma are divided into low, intermediate and high 
grade types on the basis of morphologic and cytologic features. The 
histological features that are most useful in predicting high grade, 
aggressive behavior includes intracystic component less that 20%, high 
mitotic activity, presence of neural invasion, necrosis and cellular 
anaplasia, Auclair PL et al  loc.cit (1992) . One of our case was 
categorized on high grade mucoepidermoid carcinoma due to 
predominance of the epidermoid  component with marked cellular 
anaplasia. The other two cases were categorized as low grade tumor.  
Acinic cell carcinoma 
These are group of malignant salivary gland tumor in which the 
neoplastic cells demonstrates serous acinar cell differentiation. Spiro RH 
(1986) loc.cit had found an incidence of 10% of the primary malignant 
tumors. In our study, the incidences are slightly higher to around 23% and 
this could be due to the smaller sample size of lesions. All the 3 cases of 
acinic cell carcinoma occurred in the parotid region akin to the 
observations of Spiro RH loc.cit (1986) who found more there 80% of 
these tumors occur in parotids. It is a female predominant tumor and the 
mean age is 44 years. In our study it was more common in women and we 
had a single case presenting in a male patient. The mean age of the 
patients in our study was 51. It was a slow growing mass and one of our 
case experienced facial muscle weakness. Ellis GL and Corio RL (1983) 
have reported a facial muscle weakness in 5-10% of their patients. 
Regarding the histoarchitecture, 2 of our cases presented with 
predominant solid pattern and we had a single case with microcystic 
pattern. This microcystic pattern  of acinic cell tumor occurred in a young   
lady 28 year old presenting with a nodule in parotid. 
Adenocarcinoma (NOS)  
Salivary gland adenocarcinoma (NOS) fails to exhibit prominence  
of any of the histomorphological features that characterise the more 
specific carcinoma types. Auclair PL and Ellis GL (1991) have reported 
an incidence of 8.8% and 44.7% of all malignant tumors. In our series it 
contributed 15.3% of all malignant salivary gland tumors. Both the cases 
presented with mass in the parotid region. One of them presented with 
facial muscle weakness.  
Microscopically it is composed of a heterogeneous, glandular, duct 
like and infiltrative growth pattern.  
These tumors are categorized into low grade, intermediate and high 
grade tumors based on the formation of ductal and tubular structures, 
mitotic activity and nuclear features. Both of our cases were included on 
high grade adenocarcinoma (NOS) .  
Adenoid cystic carcinoma  
Adenoid cystic carcinoma is a malignant neoplasm of the salivary 
ducts and myoepithelial cells. Ellis GL and Auclair PL loc.cit (1996) 
have reported an incidence of 7.5% of malignant salivary gland tumor. In 
our study it constituted 7.6% of the total malignant salivary gland tumors. 
The case from our series was a young 33 year old lady presenting 
with a gradually increasing mass of the submandibular region. The mass 
presented with pain and tenderness. Histologically the tumor showed a 
cribriform pattern of interconnecting cords and nests of tumor cells 
surrounding small cyst like structures of variable size  filled with 
basophilic and hyalinised eosinophilic material. 
 
Malignant oncocytoma  
They represent less than 1% of all salivary gland tumors, Ellis GL 
and Auclair PL loc.cit (1996).  We had a single case of malignant 
oncocytoma constituting 1.58% of the total tumor cases. 
Goode RK and Corio RL (1988) have reported a predominance of 
this tumors in the parotid gland. In our study the tumor was seen in th 
submandibular  gland  in an elderly woman.  
Microscopically the tumor was composed of large round to 
polyhedral cells arranged in sheets and island with finely granular 
eosinophilic cytoplasm and moderately pleomorphic nuclei.  
Adenosquamous carcinoma 
It is a rare neoplasm that simultaneously demonstrates carcinoma 
of the surface epithelium and salivary gland type adenocarcinoma. 
Genighty et al (1968) have described the most common sites of the tumor 
as posterior tongue, tonsillar pillars and floor of mouth. We had a single 
case of adenosquamous carcinoma of the parotid, presenting as a nodular 
mass in the parotid with surface ulceration. The lesion was painful. The 
superficial pattern of the tumor was squamous cell carcinoma and the 
deeper was that of adenocarcinoma. The zone of transition from 
squamous carcinoma to adenocarcinoma is usually evident. The tumor 
infiltrates and invades adjacent tissues. 
 
Squamous cell carcinoma 
Diagnosis of primary squamous cell carcinoma requires inclusion 
of primary disease in some other site, particularly the head and neck. 
Schneider AB et al (1977) had reported an incidence of 0.9% to 4.7%. In 
our series, we had a single case of primary squamous cell carcinoma 
contributes to 1.58% of total salivary gland tumors. 
Shemen LJ and Huvos AG (1987) have reported a mean age of 64 
years. In our study the patient was a female 60 years old with a parotid 
mass. 
Microscopically the tumors are mostly keratinizing squamous cell 
carcinomas and special stains do not disclose any intracytoplasmic mucin. 
Epithelial-Myoepithelial carcinoma 
This is a biphasic neoplasm of duct and myoepithelial cells. They 
are now recognized as low-grade adenocarcinoma, Thackray AC and 
Lucas RB (1974). 
Vanderwal JE et al (1998) have reported as average incidence of 
1% of salivary gland neoplasm. In our series it constitutes 1.5% of total 
salivary gland tumors. The predominant site of involvement is the 
parotid, Batsakis et al (1992).  
In our study the tumor occurred in the submandibular salivary 
gland. 
The characteristic histomorphology is a biphasic cellular pattern of 
ductal elements composed of cuboidal cells surrounded by large clear 
staining myoepithelial cells. 
Incidence of salivary gland tumors reported from various countries 
 
S.No. 
Author Country/State
Sex Tumor type 
Male   
% 
Female  
% 
Benign 
% 
Malignan
t % 
1. Satko et al (2000) Slovakia  47.41  52.59  74  26  
2. Jayaram & 
Dashini (2001) 
Malaysia  <50 >50 71.4  25.77  
3. Gill et al. (2001) Pakistan  65.7  34.3  - - 
4. Kolude et al. 
(2001) 
Nigeria  46.51  53.49  49.9 50.1  
5. Nagarkar et al. 
(2004) 
Chandigarh - - 75 25 
6. Lima et al.(2005) Portuguese  <50 >50 76.33 23.67 
7. Bandyo padhyal et 
al. (2005) 
West Bengal  - - 81.84 18.16 
8. Ansari (2007) Iran  40 60 68.4 31.6 
9. Ladeinde et al. 
(2007) 
Nigeria  52.38 47.62 39.2 60.8 
10. Subhashraj (2008) Pondicherry  - - 62 38 
11.  Li et al. (2008) China  53.5 46.5 - - 
12. Musani et al. 
(2008) 
Pakistan  42.65 57.35 74.5 25.5 
13. De oliveira et al. 
(2009) 
Brazil  39 61 78.3 21.7 
14. Dhanuthai et al. 
(2009) 
Thailand  42.02 57.98 47.2 52.7 
15. Wierzbicka et al. 
(2010) 
Poland  - - 86.76 13.23 
 
 
 
SUMMARY AND CONCLUSION 
This study analyzed the incidence and distribution of salivary gland 
lesions over a period of 5 years from the specimen submitted to the 
pathology department of Tirunelveli Medical College during the period 
between 2006 to 2010. 
Distribution of lesions recorded were neoplasm 78.75%, 
sialadenitis 20% and sialolithasis 1.25%.  Lesions occurred from 10 years 
to 80 years of age with the mean age of 41.19.  There is predominance of 
lesions in females than males was seen.  Parotid gland was mostly 
affected followed by submandibular gland. 
Tumour was recorded from 10 to 80 years of age and 76.19% of 
tumours occurred at the age group of 20 to 60 years.  Most of  the benign 
tumour was seen in the second and third decades while malignant was in 
fifth decade of life.  Females were mostly affected then males.  Most 
tumours were in the parotid gland followed by submandibular gland.  
Most common benign tumour was pleomorphic adenoma while malignant 
tumour was mucoepidermoid carcinoma and acinic cell carcinoma. 
Sialadenitis was most common non neoplastic lesion and seen 
between 15 to 56 years of age.  It was seen mostly in females then males.  
Submandibular gland was mostly affected followed by parotid gland. 
Analysis of the lesions showed statistically significant difference in 
age, sex, site distribution except submandibular sialadenitis and age 
distribution of malignant tumour. 
MASTER CHART 
 
S.No OP/IP No. M/F Age  
Neoplasm / 
Nonneoplasm 
Non 
neoplastic 
Condition 
Benign/ 
Malignant Neoplasm type Organ affected 
1 59/06 F 45 Neoplasm - Benign Pleomorphic adenoma Parotid 
2 199/06 F 28 Neoplasm - Benign Pleomorphic adenoma Parotid 
3 202/06 F 37 Neoplasm - Benign Monomorphic adenoma Parotid 
4 267/06 F 33 Non neoplasm Sialadenitis - - Submandibular gland 
5 310/06 F 50 Neoplasm - Benign Pleomorphic adenoma Parotid 
6 439/06 F 38 Non neoplasm sialadenitis - - Parotid 
7 695/06 F 39 Neoplasm -  Pleomorphic adenoma Parotid 
8 819/06 F 10 Neoplasm  - Pleomorphic adenoma Submandibular gland 
9 946/06 M 16 Neoplasm -  Pleomorphic adenoma Accessary salivary gland 
10 1061/06 M 37 Neoplasm  Benign Mixed parotid tumour Parotid 
11 1126/06 F 55 Neoplasm  Benign Pleomorphic adenoma Parotid 
12 1144/06 M 26 Neoplasm   Pleomorphic adenoma Parotid 
13 1223/06 F 45 Neoplasm   Pleomorphic adenoma Parotid 
14 1365/06 F 55 Non neoplasm Sialadenitis  - Submandi bular gland 
15 1448/06 F 42 Non neoplasm Sialadenitis  - Submendibular gland 
16 234/07 F 24 Neoplastic  Malignant Mucoepidermoid carcinomra Parotid 
17 307/07 F 48 Neoplasm  Benign cpleomorphic adenoma Parotid 
18 32/07 F 55 Neoplasm  Benign Pleomorphic adenoma Parotid 
19 659/07 F 36 Neoplasm  Malignant Adenosquamous carcinoma Parotid 
20 720/07 M 80 Neoplasm  Benign Pleomorphic adenoma Parotid 
21 804/07 F 40 Neoplasm  Benign Pleomorphic adenoma Submandibular gland 
22 924/07 M 60 Neoplasm  Benign Warthin’s tumour Submandibular gland 
23 1063/07 M 38 Neoplasm   Pleomorphic adenome Parotid 
24 1080/07 F 20 Neoplasm   Pleomorphic adenoma Parotid 
25 1119/07 M 39 Neoplasm   Pleomorphic adenoma Parotid 
26 1439/07 F 50 Neoplasm  Malignant Adenocarcinoma Parotid 
27 1442/07 M 50 Neoplasm  Benign Pleomorphic adenoma Parotid 
28 1492/07 F 25 Neoplasm  Benign Warthin’s tumour Parotid 
29 1626/07 M 73 Neoplasm  Benign Pleomorphic adenoma Parotid 
30 79/08 M 39 Nonneoplasm Sialadenitis - - Submandibular gland 
31 204/08 M 40 Non neoplasm Sialadentis  - Submandibular gland 
32 317/08 F 48 Nonneoplams Sialolithiasis  - Submandibular gland 
33 331/08 F 35 Neonneoplams -  Pleomorphic adenoma Parotid 
34 383/08 M 17 Neoplasm -  Pleomorphic adenoma Submandibular gland 
35 394/08 F 30 Neoplasm - Benign Pleomorphic adenoma Parotid 
36 471/08 F 28 Neoplasm  Benign Pleomorphic adenoma Parotid 
37 546/08 F 45 Neoplasm  Benign Pleomorphic adenoma Parotid 
38 628/08 M 65 Neoplasm   Pleomorphic adenoma Parotid 
39 802/08 F 40 Neoplasm   Pleomorphic adenoma Parotid 
40 907/08 F 48 Neoplasm   Pleomorphic adenoma Parotid 
41 1041/08 F 32 Neoplasm   Pleomorphic adenoma Parotid 
42 1150/08 F 40 Neoplasm  Malignant Mucoepidermoid Parotid 
carcinoma 
43 1216/08 M 56 Non neoplasm Chronic sialadenitis - - 
Submandibular 
gland 
44 1221/08 F 38 Non neoplasm Chronic sialadenitis - - Parotid 
45 1420/08 F 65 Neoplasm   Pleomorphic adenoma Parotid 
46 1466/08 F 28 Neoplasm - Malignant Acinic cell carcinoma Parotid 
47 1487/08 M 54 Neoplasm  Benign Pleomorphic adenoma Sublingual gland 
48 1558/08 M 40 Neoplasm Chronic sialadenitis  - 
Submandibular 
gland 
49 1596/09 M 70 Neoplasm - Benign Pleomorphic adenoma Parotid 
50 2180/09 F 23 Neoplasm   Pleomorphic adenoma Parotid 
51 2202/09 F 40 
Neoplasm 
 Malignant 
Epithelial – 
Myoepithelial 
carcinoma 
Submandibular 
gland 
52 2401/09 F 65 Nonneoplanm  Benign Basal cell adenoma Parotid 
53 147/09 F 45  Chronic sialadenitis  - 
Submandibular 
gland 
54 170/09 F 36 Neoplasm - Benign Pleomorphic adenoma Parotid 
55 2449/09 M 65 Neoplasm  Malignant Mucoepidermoid tumour Parotid 
56 393/09 F 26 Neoplasm  Benign Benign lymphoepithelial cyst Parotid 
57 526/09 M 45 Neoplasm  Benign Myoepithelioma with cystic degeneration Parotid 
58 584/09 F 55 
Neoplasm 
 Benigns Malignant 
Benign mixed tumour 
& high grade 
adenocercinoma  
Parotid 
59 608/09 M 27   Benign pleomorphicadenoma Parotid 
60 619/09 F 52 Nonneoplasm Chronic sialadenitis -  
Submandibular 
gland 
61 1032/09 F 33 Neoplasm  Malignant Adenoid cystic carcinoma 
Submandibulan 
gland 
62 1213/09 M 20 Non neoplasm Chronic sialadenitis - - 
Submandibulan 
gland 
63 1214/09 F 50 Neoplasm  Malignant Acinic cell tumor Parotid 
64 1252/09 F 15 Non neoplasm Sialadenitis   Parotid 
65 1371/09 M 40 Neoplasm  Benign Pleomorphic adenoma Hard palate 
66 4/10 F 73 Neoplasm  Malignant Malignant Oncocytoma 
Submandibular 
gland 
67 185/10 F 60 Neoplasm  Benign Pleomorphic adenoma Parotid 
68 326/10 F 24 Neoplasm   Pleomorphic adenoma Submandibular gland 
69 507/10 M 34 Neoplasm   Pleomorphic adenoma Parotid 
70 1807/10 F 23 Neoplasm  Benign Pleomorphic adenoma Submandibular gland 
71 553/10 M 76 Neoplasm  Malignant Acinic cell tumour Parotid 
72 567/10 F 29 Nonneoplasm Chronic sialadenitis  - 
Submandibular 
gland 
73 658/10 F 36 Nonneoplasm Chronic sialadenitis  - Parotid 
74 707/10 M 30 Nonneoplasm Chronic sialadenitis  - Parotid 
75 922/10 F 25 Neoplasm - Benign Pleomorphic adenoma Parotid 
76 976/10 F 60 Neoplasm  Malignant 
Well differentiated 
squamous cell 
carcinoma 
Parotid 
77 981/10 F 35 Neoplasm   Pleomorphic adenoma Parotid 
78 984/10 M 42 Neoplasm   Pleomorphic adenoma Parotid 
79 1391/10 F 34 Neoplasm  Benign Myoepithelioma Parotid 
80 1405/10 F 25 Neoplasm  Benign Benign lymphoepithelial cyst Parotid 
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